Seelos Therapeutics, Inc. (NASDAQ:SEEL – Get Free Report)’s stock price dropped 4.3% during mid-day trading on Monday . The company traded as low as $0.22 and last traded at $0.22. Approximately 14,087 shares traded hands during trading, a decline of 92% from the average daily volume of 174,745 shares. The stock had previously closed at $0.23.
Seelos Therapeutics Stock Performance
The business has a fifty day moving average of $0.55 and a 200-day moving average of $4.02.
About Seelos Therapeutics
Seelos Therapeutics, Inc, a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company's lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in patients with major depressive disorders; SLS-005, a protein stabilizer for the treatment of amyotrophic lateral sclerosis and Sanfilippo syndrome; and SLS-006, a partial dopamine agonist for the treatment of patients with Parkinson's disease (PD).
Featured Stories
- Five stocks we like better than Seelos Therapeutics
- How to Use Stock Screeners to Find Stocks
- 3 Must-Hold Stocks with Double-Digit Upside for 2025
- How to Calculate Retirement Income: MarketBeat’s Calculator
- Micron: Why Now Is the Time to Be Brave
- What is the Australian Securities Exchange (ASX)
- 3 Stocks That Wall Street Insiders Can’t Stop Buying
Receive News & Ratings for Seelos Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Seelos Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
